Prostaglandin E2 promotes cellular recovery from established nephrotoxic serum nephritis in mice, prosurvival, and regenerative effects on glomerular cells

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 5, 2013, Pages

  Kvirkvelia, Nino ^a   McMenamin, Malgorzata ^a   Chaudhary, Kapil ^a   Bartoli, Manuela ^a   Madaio, Michael P ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Apoptosis; Nephritis; NTS; Recovery; Synaptopodin

Indexed keywords

F ACTIN; PROSTAGLANDIN E2; PROSTANOID; SYNAPTOPODIN; SYNAPTOPHYSIN; SYNPR PROTEIN, MOUSE;

ACTIN FILAMENT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASCITES; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL REGENERATION; CELL STRUCTURE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; KIDNEY DEVELOPMENT; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SURVIVAL; UPREGULATION; UREA NITROGEN BLOOD LEVEL; UREMIA; WEIGHT GAIN; ANIMAL; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GLOMERULUS; INFLAMMATION; METABOLISM; NEPHRITIS; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ANIMALS; APOPTOSIS; CELL SURVIVAL; DINOPROSTONE; FEMALE; INFLAMMATION; KIDNEY GLOMERULUS; MICE; NEPHRITIS; SEVERITY OF ILLNESS INDEX; SYNAPTOPHYSIN;

MLCS; MLOWN;

EID: 84874631711     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00575.2012     Document Type: Article

References (41)

1. Akis N, Madaio MP. Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int 65: 2223-2227, 2004.
2. Aronoff DM, Bergine IL, Lewisb C, Goelf D, O'Brienf E, Peters-Goldend M, Mancusod P. E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumonia. Prostaglandins Other Lipid Mediat 98: 23-30, 2012.
3. Arsic N, Bendris N, Peter M, Begon-Pescia C, Rebouissou C, Gadéa G, Bouquier N, Bibeau F, Lemmers B, Blanchard JM. A novel function of cyclin A2: control of cell invasion via RhoA signaling. J Cell Biol 196: 147-162, 2012.
4. Audoly LP, Ma L, Feoktistov I, de Foe SK, Breyer MD, Breyer RM. Prostaglandin E-prostanoid-3 receptor activation of cyclic AMP response element-mediated gene transcription. J Pharmacol Exp Ther 289: 140-148, 1999.
5. Bondesen BA, Mills ST, Pavlath GK. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol 290: C1651-C1659, 2006.
6. Bunce CM, Velica P. Prostaglandins in muscle regenaration. J Muscle Res Cell Motil 29:163-167, 2008.
7. Cattell V, Smith J, Cook HT. Prostaglandin E1 suppresses macrophage infiltration and ameliorates injury in an experimental model of macrophagedependent glomerulonephritis. Clin Exp Immunol 79: 260-265, 1990.
8. Chan & Moore AR MM. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J Immunol 184: 6418-6426, 2010.
9. Christensen M, Su AW, Snyder RW, Greco A, Lipschutz JH, Madaio MP. Simvastatin protection against acute immune-mediated glomerulonephritis in mice. Kidney Int 69: 457-463, 2006.
10. Couser WG:. Mechanisms of glomerular injury: an overview. Semin Nephrol 11: 254-258, 1991.
11. Feng C, Beller EM, Bagga S, Boyce JA. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. Blood 107: 3243-3250, 2006.
12. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79, 2003.
13. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875, 2001.
14. Goessling W, Allen RS, Guan X, Jin P, Uchida N, Dovey M, Harris JM, Metzger ME, Bonifacino AC, Stroncek D, Stegner J, Armant M, Schlaeger T, Tisdale JF, Zon LI, Donahue RE, North TE. Prostaglandin E2 enhances human cord blood stem cell Xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 8: 445-458, 2011.
15. Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, Zon LI. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136: 1136-1147, 2009.
16. Hatae N, Sugimoto Y, Ichikawa A. Prostaglandin receptors: advances in the study of EP3 receptor signaling. J Biochem 131: 781-784, 2002.
17. Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113: 5444-5455, 2004.
18. Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB, Kunkel TA, van Harn T, Xia B, Correll M, Quackenbush J, Livingston DM, Gygi SP, Sicinski P. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature 474: 230-234, 2011.
19. Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 203: 789-797, 2006.
20. Kim EY, Suh JM, Chiu YH, Dryer SE. Regulation of podocyte BKCa channels by synaptopodin, Rho, and actin microfilaments. Am J Physiol Renal Physiol 299: F594-F604, 2010.
21. Komatsu K, Kobune-Fujiwara Y, Andoh A, Ishiguro S, Hunai H, Suzuki N, Kameyama M, Murata K, Miyoshi J, Akedo H, Tatsuta M, Nakamura H. Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br J Cancer 83: 769-774, 2000.
22. Madaio MP, Salant DJ, Adler S, Couser WG. Effect of antibody charge and concentration on deposition of antibody to glomerular basement membrane. Kidney Int 26: 397-403, 1984.
23. Mathieson PW. Podocyte actin in health, disease and treatment. Nephrol Dial Transplant 25: 1772-1773, 2010.
24. Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Jackson EK, Johnson JT, Gorelik E, Lang S, Whiteside TL. Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J Biol Chem 285: 27571-275780, 2010.
25. Martin M, Meyer-Kirchrath J, Kaber G, Jacoby C, Flogel U, Schrader J, Ruther U, Schror K, Hohlfeld T. Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury. Circulation 112: 400-406, 2005.
26. Mathienson PW. Podocyte actin in health, disease and treatment. Nephol Dial Transplant 25: 1772-1773, 2010.
27. Mendrick DL, Rennke HG, Cotran RS, Springer TA, Abbas AK. Monoclonal antibodies against rat glomerular antigens: production and specificity. Lab Invest 49: 107-117, 1983.
28. Nakagawa N, Yuhki K, Kawabe J, Fujino T, Takahata O, Kabara M, Abe K, Kojima F, Kashiwagi H, Hasebe N, Kikuchi K, Sugimoto Y, Narumiya S, Ushikubi F. The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. Kidney Int 82: 158-171, 2012.
29. Orikasa M, Matsui K, Oite T, Shimizu F. Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol 141: 807-814, 1988.
30. Otsuka S, Aoyama T, Furu M, Ito K, Jin Y, Nasu A, Fukiage K, Kohno Y, Maruyama T, Kanaji T, Nishiura A, Sugihara H, Fujimura S, Otsuka T, Nakamura T, Toguchida J. PGE2 signal via EP2 receptors evoked by a selective agonist enhances regeneration of injured articular cartilage. Osteoarthritis Cartilage 17: e529-e538, 2009.
31. Raychaudhury P, Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res 71: 4329-4333, 2011.
32. Rusnak F, Mertz P. Calcineurin: form, function. Physiol Rev 80: 1483-1521, 2000.
33. Ruwart MJ, Rush BD, Friedle NM, Piper RC, Kolaja GJ. Protective effects of 16,16-dimethyl PGE2 on the liver and kidney. Prostaglandins 21, Suppl 97-102, 1981.
34. Salant DJ, Belok S, Madaio MP, Couser WG. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 66: 1339-1350, 1980.
35. Shi J, Johansson J, Woodling NS, Wang Q, Montine TJ, Andreasson K. The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J Immunol 184: 7207-7218, 2010.
36. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387-343, 2004.
37. Tarzi RM, Davies KA, Classens JW, Verbeek JS, Walport MJ, Cook HT. Both Fc gamma receptor I and Fc gamma receptor III mediate disease in accelerated nephrotoxic nephritis. Am J Pathol 162: 1677-1683, 2003.
38. Vlahakos D, Foster MH, Ucci AA, Barrett KJ, Datta SK, Madaio MP. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. Am Soc Nephol 2: 1345-1354, 1992.
39. Vio CP, Quiroz-Munoz M, Cuevas CA, Cespedes C, Ferreri NR. Prostaglandin E2 EP3 receptor regulates cyclooxygenase-2 expression in the kidney. Am J Physiol Renal Physiol 303: F449-F457, 2012.
40. Welsh GI, Saleem MA. The podocyte cytoskeleton-key to a functioning glomerulus in health and disease. Nat Rev Nephrol 8: 14-21, 2012.
41. Zhu Z, Fu C, Li X, Song Y, Li C, Zou M, Guan Y, Zhu Y. Prostaglandin E2 promotes endothelial differentiation from bone marrowderived cells through AMPK activation. PLos One 6: e23554, 2011.